Pressure Biosciences Inc (PBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,314 | -16,077 | -20,154 | -16,006 | -11,661 |
| Depreciation Amortization | 2,620 | 1,898 | 6,849 | 5,558 | 1,477 |
| Accounts receivable | 144 | -141 | -24 | 98 | 245 |
| Accounts payable and accrued liabilities | 683 | 109 | -227 | -44 | 157 |
| Other Working Capital | 4,135 | 3,023 | 202 | 4,028 | 1,417 |
| Other Operating Activity | 18,546 | 6,709 | 8,484 | 1,482 | 2,037 |
| Operating Cash Flow | $-3,186 | $-4,478 | $-4,869 | $-4,883 | $-6,328 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -21 | -123 | -2 | -23 |
| Other Investing Activity | 0 | 0 | 0 | -795 | 0 |
| Investing Cash Flow | $-8 | $-21 | $-123 | $-797 | $-23 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,615 | 2,710 | 2,265 | 1,291 | 2,982 |
| Debt Issued | 5,639 | 5,774 | 5,514 | 8,581 | 6,845 |
| Debt Repayment | -2,927 | -1,838 | -2,188 | -3,056 | -4,590 |
| Common Stock Issued | 231 | 42 | 15 | N/A | N/A |
| Other Financing Activity | -2,286 | -2,318 | -501 | -1,146 | 1,040 |
| Financing Cash Flow | $3,271 | $4,370 | $5,105 | $5,669 | $6,278 |
| Beginning Cash Position | 4 | 132 | 19 | 30 | 103 |
| End Cash Position | 81 | 4 | 132 | 19 | 30 |
| Net Cash Flow | $77 | $-128 | $114 | $-11 | $-74 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,186 | -4,478 | -4,869 | -4,883 | -6,328 |
| Capital Expenditure | -8 | -21 | -123 | -2 | -23 |
| Free Cash Flow | -3,194 | -4,499 | -4,992 | -4,885 | -6,351 |